NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Terminal/Device DB/Kernel Flow (TD-fNIRS)
EEGnonecommercial

Kernel Flow (TD-fNIRS)

Implant Type
EEG
Electrodes
52
Channels
52
FDA Status
none
Status
commercial
About

Kernel Flow is a wearable time-domain functional near-infrared spectroscopy (TD-fNIRS) system designed for high-temporal-resolution measurement of hemodynamic brain activity. Unlike EEG, which measures electrical potentials, fNIRS measures changes in blood oxygenation as a proxy for neural activity, providing complementary spatial information with better depth penetration than scalp EEG. The Flow helmet contains 52 modules, each with a laser source and two detectors, arranged across a full-head array. Kernel targets neuroscience research, pharmaceutical clinical trials requiring objective neural biomarkers, and enterprise cognitive wellness applications. Founded by Braintree co-founder Bryan Johnson, who self-funded the company.

Target Conditions
neuroscience researchcognitive assessmentpharmaceutical biomarkersmental wellness
Milestones
2016-01Kernel founded by Bryan Johnson
2020-08$53M funding announced (self-funded by Johnson)
2021-11Kernel Flow released for research partners
2022-06Kernel Flux (MEG-based system) announced alongside Flow
FDA Regulatory Pathway
No FDA Regulatory Status

This device does not have a current FDA designation. It may be a research tool, preclinical device, or consumer product not subject to FDA medical device regulation.

FDA Device Regulatory Guidance ↗
Other EEG Devices